References analysis of the Wikipedia article "Lactoferrina" in the Galician version

doi.org

dx.doi.org

Sánchez L, Calvo M, Brock JH (1992). "Biological role of lactoferrin". Arch. Dis. Child. 67 (5): 657–61. PMC 1793702. PMID 1599309. doi:10.1136/adc.67.5.657.

Groves ML (1960). "The Isolation of a Red Protein from Milk". Journal of the American Chemical Society 82 (13): 3345. doi:10.1021/ja01498a029.

Johansson B, Virtanen AI, Tweit RC, Dodson RM (1960). "Isolation of an iron-containing red protein from human milk" (PDF). Acta Chem. Scand. 14 (2): 510–512. doi:10.3891/acta.chem.scand.14-0510. Arquivado dende o orixinal (PDF) o 06 de xullo de 2011. Consultado o 26 de setembro de 2014.

Birgens HS (1985). "Lactoferrin in plasma measured by an ELISA technique: evidence that plasma lactoferrin is an indicator of neutrophil turnover and bone marrow activity in acute leukaemia". Scand J Haematol 34 (4): 326–31. PMID 3858982. doi:10.1111/j.1600-0609.1985.tb00757.x.

Baker EN, Baker HM (2005). "Molecular structure, binding properties and dynamics of lactoferrin". Cell. Mol. Life Sci. 62 (22): 2531–9. PMID 16261257. doi:10.1007/s00018-005-5368-9.

Håkansson A, Zhivotovsky B, Orrenius S, Sabharwal H, Svanborg C (1995). "Apoptosis induced by a human milk protein". Proc. Natl. Acad. Sci. U.S.A. 92 (17): 8064–8. PMC 41287. PMID 7644538. doi:10.1073/pnas.92.17.8064.

Jameson GB, Anderson BF, Norris GE, Thomas DH, Baker EN (1998). "Structure of human apolactoferrin at 2.0 Å resolution. Refinement and analysis of ligand-induced conformational change". Acta Crystallogr. D Biol. Crystallogr. 54 (Pt 6 Pt 2): 1319–35. PMID 10089508. doi:10.1107/S0907444998004417.

Mazurier J, Spik G (1980). "Comparative study of the iron-binding properties of human transferrins. I. Complete and sequential iron saturation and desaturation of the lactotransferrin". Biochim. Biophys. Acta 629 (2): 399–408. PMID 6770907. doi:10.1016/0304-4165(80)90112-9.

Shongwe MS, Smith CA, Ainscough EW, Baker HM, Brodie AM, Baker EN (1992). "Anion binding by human lactoferrin: results from crystallographic and physicochemical studies". Biochemistry 31 (18): 4451–8. PMID 1581301. doi:10.1021/bi00133a010.

Mantel C, Miyazawa K, Broxmeyer HE (1994). "Physical characteristics and polymerization during iron saturation of lactoferrin, a myelopoietic regulatory molecule with suppressor activity". Adv. Exp. Med. Biol. Advances in, Experimental Medicine and Biology 357: 121–32. ISBN 978-0-306-44734-1. PMID 7762423. doi:10.1007/978-1-4615-2548-6_12.

Furmanski P, Li ZP, Fortuna MB, Swamy CV, Das MR (1989). "Multiple molecular forms of human lactoferrin. Identification of a class of lactoferrins that possess ribonuclease activity and lack iron-binding capacity". J. Exp. Med. 170 (2): 415–29. PMC 2189405. PMID 2754391. doi:10.1084/jem.170.2.415.

Farnaud S, Evans RW (2003). "Lactoferrin—a multifunctional protein with antimicrobial properties". Mol. Immunol. 40 (7): 395–405. PMID 14568385. doi:10.1016/S0161-5890(03)00152-4.

Xanthou M (1998). "Immune protection of human milk". Biol. Neonate 74 (2): 121–33. PMID 9691154. doi:10.1159/000014018.

Odell EW, Sarra R, Foxworthy M, Chapple DS, Evans RW (1996). "Antibacterial activity of peptides homologous to a loop region in human lactoferrin". FEBS Lett. 382 (1–2): 175–8. PMID 8612745. doi:10.1016/0014-5793(96)00168-8.

Kuwata H, Yip TT, Yip CL, Tomita M, Hutchens TW (1998). "Bactericidal domain of lactoferrin: detection, quantitation, and characterization of lactoferricin in serum by SELDI affinity mass spectrometry". Biochem. Biophys. Res. Commun. 245 (3): 764–73. PMID 9588189. doi:10.1006/bbrc.1998.8466.

Sojar HT, Hamada N, Genco RJ (1998). "Structures involved in the interaction of Porphyromonas gingivalis fimbriae and human lactoferrin". FEBS Lett. 422 (2): 205–8. PMID 9490007. doi:10.1016/S0014-5793(98)00002-7.

Andrés MT, Fierro JF (2010). "Antimicrobial mechanism of action of transferrins: Selective inhibition of H+-ATPase". Antimicrob. Agents Chemother. 54 (10): 4335–42. PMC 2944611. PMID 20625147. doi:10.1128/AAC.01620-09.

van der Strate BW, Beljaars L, Molema G, Harmsen MC, Meijer DK (2001). "Antiviral activities of lactoferrin". Antiviral Res. 52 (3): 225–39. PMID 11675140. doi:10.1016/S0166-3542(01)00195-4.

Fujihara T, Hayashi K (1995). "Lactoferrin inhibits herpes simplex virus type-1 (HSV-1) infection to mouse cornea". Arch. Virol. 140 (8): 1469–72. PMID 7661698. doi:10.1007/BF01322673.

Giansanti F, Rossi P, Massucci MT, Botti D, Antonini G, Valenti P, Seganti L (2002). "Antiviral activity of ovotransferrin discloses an evolutionary strategy for the defensive activities of lactoferrin". Biochem. Cell Biol. 80 (1): 125–30. PMID 11908636. doi:10.1139/o01-208.

Harmsen MC, Swart PJ, de Béthune MP, Pauwels R, De Clercq E, The TH, Meijer DK (1995). "Antiviral effects of plasma and milk proteins: lactoferrin shows potent activity against both human immunodeficiency virus and human cytomegalovirus replication in vitro". J. Infect. Dis. 172 (2): 380–8. PMID 7622881. doi:10.1093/infdis/172.2.380.

Puddu P, Borghi P, Gessani S, Valenti P, Belardelli F, Seganti L (1998). "Antiviral effect of bovine lactoferrin saturated with metal ions on early steps of human immunodeficiency virus type 1 infection". Int. J. Biochem. Cell Biol. 30 (9): 1055–62. PMID 9785469. doi:10.1016/S1357-2725(98)00066-1.

Azzam HS, Goertz C, Fritts M, Jonas WB (2007). "Natural products and chronic hepatitis C virus". Liver Int. 27 (1): 17–25. PMID 17241377. doi:10.1111/j.1478-3231.2006.01408.x.

Nozaki A, Ikeda M, Naganuma A, Nakamura T, Inudoh M, Tanaka K, Kato N (2003). "Identification of a lactoferrin-derived peptide possessing binding activity to hepatitis C virus E2 envelope protein". J. Biol. Chem. 278 (12): 10162–73. PMID 12522210. doi:10.1074/jbc.M207879200.

Arnold D, Di Biase AM, Marchetti M, Pietrantoni A, Valenti P, Seganti L, Superti F (2002). "Antiadenovirus activity of milk proteins: lactoferrin prevents viral infection". Antiviral Res. 53 (2): 153–8. PMID 11750941. doi:10.1016/S0166-3542(01)00197-8.

Reghunathan R, Jayapal M, Hsu LY, Chng HH, Tai D, Leung BP, Melendez AJ (2005). "Expression profile of immune response genes in patients with Severe Acute Respiratory Syndrome". BMC Immunol. 6: 2. PMC 546205. PMID 15655079. doi:10.1186/1471-2172-6-2.

Wakabayashi H, Uchida K, Yamauchi K, Teraguchi S, Hayasawa H, Yamaguchi H (2000). "Lactoferrin given in food facilitates dermatophytosis cure in guinea pig models". J. Antimicrob. Chemother. 46 (4): 595–602. PMID 11020258. doi:10.1093/jac/46.4.595.

Lupetti A, Paulusma-Annema A, Welling MM, Dogterom-Ballering H, Brouwer CP, Senesi S, Van Dissel JT, Nibbering PH (2003). "Synergistic activity of the N-terminal peptide of human lactoferrin and fluconazole against Candida species". Antimicrob. Agents Chemother. 47 (1): 262–7. PMC 149030. PMID 12499200. doi:10.1128/AAC.47.1.262-267.2003.

Viejo-Díaz M, Andrés MT, Fierro JF (2004). "Modulation of in vitro fungicidal activity of human lactoferrin against Candida albicans by extracellular cation concentration and target cell metabolic activity". Antimicrob. Agents Chemother. 48 (4): 1242–8. PMC 375254. PMID 15047526. doi:10.1128/AAC.48.4.1242-1248.2004.

Takakura N, Wakabayashi H, Ishibashi H, Teraguchi S, Tamura Y, Yamaguchi H, Abe S (2003). "Oral lactoferrin treatment of experimental oral candidiasis in mice". Antimicrob. Agents Chemother. 47 (8): 2619–23. PMC 166093. PMID 12878528. doi:10.1128/AAC.47.8.2619-2623.2003.

Masci JR (outubro de 2000). "Complete response of severe, refractory oral candidiasis to mouthwash containing lactoferrin and lysozyme". AIDS 14 (15): 2403–4. PMID 11089630. doi:10.1097/00002030-200010200-00023.

Bharadwaj S, Naidu AG, Betageri GV, Prasadarao NV, Naidu AS (setembro de 2009). "Milk ribonuclease-enriched lactoferrin induces positive effects on bone turnover markers in postmenopausal women". Osteoporos Int 20 (9): 1603–11. PMID 19172341. doi:10.1007/s00198-009-0839-8.

Bharadwaj S, Naidu TA, Betageri GV, Prasadarao NV, Naidu AS (novembro de 2010). "Inflammatory responses improve with milk ribonuclease-enriched lactoferrin supplementation in postmenopausal women". Inflamm. Res. 59 (11): 971–8. PMID 20473630. doi:10.1007/s00011-010-0211-7.

McCormick JJ, Larson LJ, Rich MA (1974). "RNase inhibition of reverse transcriptase activity in human milk". Nature 251 (5477): 737–40. PMID 4139659. doi:10.1038/251737a0.

Das MR, Padhy LC, Koshy R, Sirsat SM, Rich MA (1976). "Human milk samples from different ethnic groups contain RNase that inhibits, and plasma membrane that stimulates, reverse transcription". Nature 262 (5571): 802–5. PMID 60710. doi:10.1038/262802a0.

Tsuda H, Sekine K, Fujita K, Ligo M (2002). "Cancer prevention by bovine lactoferrin and underlying mechanisms--a review of experimental and clinical studies". Biochem. Cell Biol. 80 (1): 131–6. PMID 11908637. doi:10.1139/o01-239.

Chandra Mohan KV, Kumaraguruparan R, Prathiba D, Nagini S (setembro de 2006). "Modulation of xenobiotic-metabolizing enzymes and redox status during chemoprevention of hamster buccal carcinogenesis by bovine lactoferrin". Nutrition 22 (9): 940–6. PMID 16928475. doi:10.1016/j.nut.2006.05.017.

Jing-Fen Kang, Xiang-Long Li, Rong-Yan Zhou, Lan-Hui Li, Fu-Jun Feng and Xiu -Li Guo (2008). "Bioinformatics Analysis of Lactoferrin Gene for Several Species". Biochemical Genetics 46 (5–6): 312–322. PMID 18228129. doi:10.1007/s10528-008-9147-9.

Seyfert HM, Tuckoricz A, Interthal H, Koczan D, Hobom G (1994). "Structure of the bovine lactoferrin-encoding gene and its promoter". Gene 143 (2): 265–9. PMID 8206385. doi:10.1016/0378-1119(94)90108-2.

O'Halloran F, Bahar B, Buckley F, O'Sullivan O, Sweeney T, Giblin L. (2009). "Characterisation of single nucleotide polymorphisms identified in the bovine lactoferrin gene sequences across a range of dairy cow breeds". Biochimie 91 (1): 68–75. PMID 18554515. doi:10.1016/j.biochi.2008.05.011.

Liao Y, Lopez V, Shafizadeh TB, Halsted CH, Lönnerdal B (2007). "Cloning of a pig homologue of the human lactoferrin receptor: expression and localization during intestinal maturation in piglets". Comp Biochem Physiol a Mol Integr Physiol 148 (3): 584–90. PMC 2265088. PMID 17766154. doi:10.1016/j.cbpa.2007.08.001.

Moskwa P, Lorentzen D, Excoffon KJ, Zabner J, McCray PB, Nauseef WM, Dupuy C, Bánfi B (2007). "A novel host defense system of airways is defective in cystic fibrosis". Am. J. Respir. Crit. Care Med. 175 (2): 174–83. PMC 2720149. PMID 17082494. doi:10.1164/rccm.200607-1029OC.

Singh PK, Schaefer AL, Parsek MR, Moninger TO, Welsh MJ, Greenberg EP (2000). "Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms". Nature 407 (6805): 762–4. PMID 11048725. doi:10.1038/35037627.

Singh PK, Parsek MR, Greenberg EP, Welsh MJ (2002). "A component of innate immunity prevents bacterial biofilm development". Nature 417 (6888): 552–5. PMID 12037568. doi:10.1038/417552a.

Rogan MP, Taggart CC, Greene CM, Murphy PG, O'Neill SJ, McElvaney NG (2004). "Loss of microbicidal activity and increased formation of biofilm due to decreased lactoferrin activity in patients with cystic fibrosis". J. Infect. Dis. 190 (7): 1245–53. PMID 15346334. doi:10.1086/423821.

Rogan MP, Geraghty P, Greene CM, O'Neill SJ, Taggart CC, McElvaney NG (2006). "Antimicrobial proteins and polypeptides in pulmonary innate defence". Respir. Res. 7 (1): 29. PMC 1386663. PMID 16503962. doi:10.1186/1465-9921-7-29.

Xavier PL, Chaudhari K, Verma PK, Pal SK, Pradeep T (2010). "Luminescent quantum clusters of gold in transferrin family protein, lactoferrin exhibiting FRET" (PDF). Nanoscale 12 (12): 2769–76. PMID 20882247. doi:10.1039/C0NR00377H.

Ohashi, Yoshiki; Reiko Ishida; Takashi Kojima; Eiki Goto; Yukihiro Matsumoto; Katsuhiko Watanabe; Naruhiro Ishida; Katsuhiko Nakata; Tsutomu Takeuchi; Kazuo Tsubota (agosto de 2003). "Abnormal Protein Profiles in Tears with Dry Eye Syndrome". American Journal of Ophthalmology 136 (2): 291–9. PMID 12888052. doi:10.1016/S0002-9394(03)00203-4.

Karns, Kelly; Herr, Amy E (novembro de 2011). "Human Tear Protein Analysis Enabled by an Alkaline Microfluidic Homogeneous Immunoassay". Analytical Chemistry 83 (21): 8115–22. PMID 21910436. doi:10.1021/ac202061v.

nih.gov

ncbi.nlm.nih.gov

Sánchez L, Calvo M, Brock JH (1992). "Biological role of lactoferrin". Arch. Dis. Child. 67 (5): 657–61. PMC 1793702. PMID 1599309. doi:10.1136/adc.67.5.657.

Baker EN, Baker HM (2005). "Molecular structure, binding properties and dynamics of lactoferrin". Cell. Mol. Life Sci. 62 (22): 2531–9. PMID 16261257. doi:10.1007/s00018-005-5368-9.

Levay PF, Viljoen M (1995). "Lactoferrin: a general review". Haematologica 80 (3): 252–67. PMID 7672721.

Bennett RM, Davis J (1982). "Lactoferrin interacts with deoxyribonucleic acid: a preferential reactivity with double-stranded DNA and dissociation of DNA-anti-DNA complexes". J. Lab. Clin. Med. 99 (1): 127–38. PMID 6274982.

Bagby GC, Bennett RM (1982). "Feedback regulation of granulopoiesis: polymerization of lactoferrin abrogates its ability to inhibit CSA production". Blood 60 (1): 108–12. PMID 6979357.

Farnaud S, Evans RW (2003). "Lactoferrin—a multifunctional protein with antimicrobial properties". Mol. Immunol. 40 (7): 395–405. PMID 14568385. doi:10.1016/S0161-5890(03)00152-4.

Xanthou M (1998). "Immune protection of human milk". Biol. Neonate 74 (2): 121–33. PMID 9691154. doi:10.1159/000014018.

van der Strate BW, Beljaars L, Molema G, Harmsen MC, Meijer DK (2001). "Antiviral activities of lactoferrin". Antiviral Res. 52 (3): 225–39. PMID 11675140. doi:10.1016/S0166-3542(01)00195-4.

Fujihara T, Hayashi K (1995). "Lactoferrin inhibits herpes simplex virus type-1 (HSV-1) infection to mouse cornea". Arch. Virol. 140 (8): 1469–72. PMID 7661698. doi:10.1007/BF01322673.

Azzam HS, Goertz C, Fritts M, Jonas WB (2007). "Natural products and chronic hepatitis C virus". Liver Int. 27 (1): 17–25. PMID 17241377. doi:10.1111/j.1478-3231.2006.01408.x.

Kuipers ME, de Vries HG, Eikelboom MC, Meijer DK, Swart PJ (1999). "Synergistic fungistatic effects of lactoferrin in combination with antifungal drugs against clinical Candida isolates". Antimicrob. Agents Chemother. 43 (11): 2635–41. PMC 89536. PMID 10543740.

Rosenmund A, Kuyas C, Haeberli A (1986). "Oxidative radioiodination damage to human lactoferrin". Biochem. J. 240 (1): 239–45. PMC 1147399. PMID 3827843.

McCormick JJ, Larson LJ, Rich MA (1974). "RNase inhibition of reverse transcriptase activity in human milk". Nature 251 (5477): 737–40. PMID 4139659. doi:10.1038/251737a0.

Singh PK, Parsek MR, Greenberg EP, Welsh MJ (2002). "A component of innate immunity prevents bacterial biofilm development". Nature 417 (6888): 552–5. PMID 12037568. doi:10.1038/417552a.

web.archive.org

"Lactoferrin: a review" (PDF). Veterinarni Medicina 53 (9): 457. 2008. Arquivado dende o orixinal (PDF) o 09 de xaneiro de 2020. Consultado o 26 de setembro de 2014.

"Public summary of positive opinion for orphan designation of hypothiocyanite/lactoferrin for the treatment of cystic fibrosis" (PDF). Pre-authorisation Evaluation of Medicines for Human Use. European Medicines Agency. 2009-09-07. Arquivado dende o orixinal (PDF) o 30 de maio de 2010. Consultado o 2010-01-23.

"Meveol: orphan drug status granted by the FDA for the treatment of cystic fibrosis". United States Food and Drug Administration. 2009-11-05. Arquivado dende o orixinal o 24 de decembro de 2009. Consultado o 2010-01-23.

Lactoferrina (Galician Wikipedia)

actachemscand.org

archive.org

bioalaxia.eu

books.google.com

doi.org

dx.doi.org

europa.eu

ema.europa.eu

ias.ac.in

repository.ias.ac.in

nih.gov

ncbi.nlm.nih.gov

vri.cz

web.archive.org